Clarity launches “Insight”, a quarterly newsletter focused on the latest in imaging
Clarity Pharmaceuticals launched “Insight”, a quarterly newsletter focussed on the latest news in the imaging industry. The first issue explored Genentech’s anti-C-MET Phase III trial, and how imaging might have changed the outcome, and looked at how imaging has been used to successfully support the ZEPHIR trial. 1. Read Issue 1 here 2. Read Issue…